- Clinically isolated syndrome (CIS) and a treatment by glatiramer acetate2014 | Publication without faculty affiliation
- Toxocara spp. seronegativity in Czech patients with early form of multiple sclerosis - Clinically isolated syndrome2017 | First Faculty of Medicine
- Clinically isolated syndrome and prognostic markers in multiple sclerosis. Why treat in time?2008 | First Faculty of Medicine
- Clinical isolated syndrome - myoclonusPublication without faculty affiliation
- Clinically isolated syndrome in early diagnosis of multiple sclerosisPublication without faculty affiliation
- Timely treatment of multiple sclerosis: practical experience2015 | First Faculty of Medicine
- Renal cell carcinoma2015 | First Faculty of Medicine
- Interferon Beta Therapy in a Patient with Clinically Isolated Syndrome - a Case Report2013 | First Faculty of Medicine
- The diagnosis and treatment of multiple sclerosis2015 | Faculty of Medicine in Hradec Králové
- Multiple sclerosis - early diagnosis and treatment options2019 | First Faculty of Medicine
- Glatirameracetate - the treatment of multiple sclerosis monitored in the ReMuS Registry2020 | Faculty of Medicine in Pilsen
- AMETYST - results of an observational phase IV clinical study evaluating the effect of intramuscular interferon beta-1a therapy in patients with clinically isolated syndrome or clinically definite multiple sclerosis2017 | First Faculty of Medicine
- Interferon beta in the current treatment of multiple sclerosis2013 | First Faculty of Medicine
- Teriflunomidu position in the treatment of multiple sclerosis2018 | Faculty of Medicine in Hradec Králové
- Cognitive impairment in early stages of multiple sclerosis2013 | First Faculty of Medicine, Second Faculty of Medicine
- AMETYST - Observational Phase IV Study Following the Influence of Intramuscularly Administered Interferon Beta-1a in Patients with Clinically Isolated Syndrome/Clinically Definite Multiple Sclerosis2014 | First Faculty of Medicine
- Glatiramer acetate and treatment of multiple sclerosis2015 | Faculty of Medicine in Hradec Králové
- Effect of subcutaneously administered interferon β-1a on disease activity in patients with clinically isolated syndrome - ATRACT observational study2019 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Current options in the treatment of multiple sclerosis2010 | Second Faculty of Medicine
- Escalation vs. induction therapy in multiple sclerosis2017 | Faculty of Medicine in Pilsen
- Biomarkers of disease course and prognosis in multiple sclerosis patients2018 | Second Faculty of Medicine
- Contemporary treatment of relapsing-remitting multiple sclerosis and future perspectives2008 | First Faculty of Medicine
- Glatiramer acetate and three case reports2016 | Faculty of Medicine in Hradec Králové
- Treatment intramuscular interferon beta-1a2013 | First Faculty of Medicine
- Ocrelizumab in clinical trials2017 | First Faculty of Medicine
- Acute pediatric myelitis - cohort of 20 patients2018 | First Faculty of Medicine, Second Faculty of Medicine